A clinical-stage sponsor managing four global Phase 2 Central Nervous System (CNS) studies faced a critical inflection point. Their fully outsourced CRO was underperforming; missed site visits, inexperienced monitors, and strained site relationships were compromising trial integrity and jeopardizing timelines.
Replacing the CRO outright would have meant months of disruption and millions in added costs. Instead, the sponsor turned to Clinovo for a more targeted solution.
KEY RESULTS
Clinovo’s rapid deployment and therapeutic alignment delivered measurable, lasting impact:
15 CNS monitors deployed in 4 weeks, each vetted for therapeutic expertise and sponsor alignment
100% resolution of missed monitoring visits, immediately closing compliance gaps
Low attrition over 24 months, compared to a 30% industry rate average — protecting institutional knowledge and continuity
Marked improvement in site engagement and inspection readiness, as reported by investigative sites
STRATEGIC IMPACT
For the sponsor, the results weren’t just operational fixes; they translated into lasting strategic gains that strengthened trial execution and safeguarded the pipeline
Stronger oversight, fewer deviations, and improved compliance¹
Direct supervision combined with therapeutic expertise built lasting confidence
Low attrition preserved study knowledge and relationships
Cost and time savings compared to wholesale vendor transition
Download the full case study to learn how Clinovo’s sponsor-aligned FSP model can stabilize your operations and de-risk your pipeline without compromise.
At Clinovo, we deliver expert-led technology and workforce optimization solutions that accelerate clinical development with targeted precision. Eliminate barriers, achieve measurable ROI, and bring life-changing therapies to market faster.
Quick Links
Contact Us
Visit Us
Copyright 2026 Clinovo | All Rights Reserved
